Compare KR & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KR | HLN |
|---|---|---|
| Founded | 1883 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Food Chains | Package Goods/Cosmetics |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9B | 43.7B |
| IPO Year | 2007 | N/A |
| Metric | KR | HLN |
|---|---|---|
| Price | $72.03 | $10.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $74.25 | N/A |
| AVG Volume (30 Days) | 5.9M | ★ 8.0M |
| Earning Date | 06-03-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.94% | 1.81% |
| EPS Growth | ★ 23.99 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $147,123,000,000.00 | N/A |
| Revenue This Year | $5.52 | $7.04 |
| Revenue Next Year | $1.92 | $4.58 |
| P/E Ratio | $313.39 | ★ $49.05 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $58.60 | $8.71 |
| 52 Week High | $74.90 | $11.42 |
| Indicator | KR | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 60.60 | 34.64 |
| Support Level | $68.11 | $9.48 |
| Resistance Level | $73.51 | $10.31 |
| Average True Range (ATR) | 1.90 | 0.17 |
| MACD | 0.28 | -0.13 |
| Stochastic Oscillator | 69.85 | 1.93 |
Kroger is one of the largest grocery retailers in the United States with about 2,700 stores across a portfolio of more than 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.